Both in Pharmaceuticals
Alzamend Neuro vs CNS Pharmaceuticals
Over the past year ALZN returned −41.4% and CNSP returned −47.3%; their daily moves had a correlation of 0.09.
ALZN −41.4% CNSP −47.3%Growth of $1, one year, split-adjusted
| Metric | ALZN | CNSP |
|---|---|---|
| Price | $1.30 | $4.85 |
| Market cap | $6.3M | $7.1M |
| Today | +1.56% | −6.30% |
| 1 month | −29.3% | −5.3% |
| 6 months | +16.1% | +91.0% |
| Year to date | −28.6% | −7.6% |
| 1 year | −44.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.6M | $20.0M |
| Dividend yield | — | — |
| Volatility (60d) | 75.6% | 71.3% |
| Short % of float | 3.3% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).